Who founded NeuroKaire?

NeuroKaire was founded by Talia Cohen Solal, Daphna Laifenfeld, Issar Yazbin in 2017.

Who are NeuroKaire's investors?

NeuroKaire's investors include Hilltop Venture Partners, Meron Capital, Sapir Venture Partners, Jumpspeed Venture Partners.

How much funding has NeuroKaire raised?

NeuroKaire has disclosed $10M raised across 1 round.

Where is NeuroKaire headquartered?

NeuroKaire is headquartered in Kearny, US.

NeuroKaire

Kearny, US · Founded 2017 · 46 employees on LinkedIn · 4 known investors

Find your way into NeuroKaire

1,350 people in our graph can introduce you to the NeuroKaire team.

Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroKaire team. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NeuroKaire uses cellular modeling and biological measurement to help mental health providers and patients make treatment decisions for depression based on measurable biological response rather than trial-and-error approaches. The company offers diagnostic testing through CLIA-certified laboratories to provide earlier biological context for antidepressant selection.

Biotech Digital Health Medical Devices Mental Health

Founders & leadership

NeuroKaire was founded in 2017 by Talia Cohen Solal, Daphna Laifenfeld, and Issar Yazbin.

Talia Cohen Solal Talia Cohen Solal is a neuroscientist with a Ph.D. from UCL focused on mental illness mechanisms, postdoctoral research experience at Columbia University, and prior roles in personalized medicine biotech including as a principal scientist.

Daphna Laifenfeld Daphna Laifenfeld held executive roles in major pharmaceutical and healthcare companies, where she led teams and business units focused on personalized medicine and diagnostics. She has expertise in healthcare data analytics, diagnostic regulation, and market access strategy.

Issar Yazbin Issar Yazbin is a product and project management executive with experience in strategic planning, business development, and leadership across product P&L management, business strategy, and partnership building.

Investors · 4

Hilltop Venture Partnerslisted by Hilltop Venture PartnersSan Diego

How we know: Hilltop Venture Partners's portfolio page · Not right? Tell us

Meron Capitallisted by Meron CapitalTel Aviv

How we know: Meron Capital's portfolio page · funding news · Not right? Tell us

Sapir Venture Partnerslisted by Sapir Venture PartnersJerusalem

How we know: Sapir Venture Partners's portfolio page · funding news · Not right? Tell us

Jumpspeed Venture PartnersreportedJerusalem

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$10M disclosed across 1 round · 2024

$10MraisedDec 2024 · 2 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

NeuroKaire Raises $10M in Fundingfinsmes.com · Dec 2024

Frequently asked questions

What does NeuroKaire do?: NeuroKaire uses cellular modeling and biological measurement to help mental health providers and patients make treatment decisions for depression based on measurable biological response rather than trial-and-error approaches. The company offers diagnostic testing through CLIA-certified laboratories to provide earlier biological context for antidepressant selection.
Who founded NeuroKaire?: NeuroKaire was founded by Talia Cohen Solal, Daphna Laifenfeld, Issar Yazbin in 2017.
Who are NeuroKaire's investors?: NeuroKaire's investors include Hilltop Venture Partners, Meron Capital, Sapir Venture Partners, Jumpspeed Venture Partners.
How much funding has NeuroKaire raised?: NeuroKaire has disclosed $10M raised across 1 round.
Where is NeuroKaire headquartered?: NeuroKaire is headquartered in Kearny, US.